213 related articles for article (PubMed ID: 15716154)
1. Apolipoprotein E and category fluency: evidence for reduced semantic access in healthy normal controls at risk for developing Alzheimer's disease.
Rosen VM; Sunderland T; Levy J; Harwell A; McGee L; Hammond C; Bhupali D; Putnam K; Bergeson J; Lefkowitz C
Neuropsychologia; 2005; 43(4):647-58. PubMed ID: 15716154
[TBL] [Abstract][Full Text] [Related]
2. Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.
Miller KJ; Rogers SA; Siddarth P; Small GW
Int J Geriatr Psychiatry; 2005 Feb; 20(2):128-36. PubMed ID: 15660408
[TBL] [Abstract][Full Text] [Related]
3. Clustering and switching in semantic fluency: predictors of the development of Alzheimer's disease.
Fagundo AB; López S; Romero M; Guarch J; Marcos T; Salamero M
Int J Geriatr Psychiatry; 2008 Oct; 23(10):1007-13. PubMed ID: 18416452
[TBL] [Abstract][Full Text] [Related]
4. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.
Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L
Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568
[TBL] [Abstract][Full Text] [Related]
5. Clustering and switching processes in semantic verbal fluency in the course of Alzheimer's disease subjects: results from the PAQUID longitudinal study.
Raoux N; Amieva H; Le Goff M; Auriacombe S; Carcaillon L; Letenneur L; Dartigues JF
Cortex; 2008 Oct; 44(9):1188-96. PubMed ID: 18761132
[TBL] [Abstract][Full Text] [Related]
6. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
7. Memory for new information as a cognitive marker of liability to Alzheimer's disease in a high risk group: a research note.
Rice F; Abraham R; Rudrasingham V; Owen MJ; Williams J
Int J Geriatr Psychiatry; 2003 Feb; 18(2):155-60. PubMed ID: 12571825
[TBL] [Abstract][Full Text] [Related]
8. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
[TBL] [Abstract][Full Text] [Related]
11. Role of the left inferior frontal gyrus in covert word retrieval: neural correlates of switching during verbal fluency.
Hirshorn EA; Thompson-Schill SL
Neuropsychologia; 2006; 44(12):2547-57. PubMed ID: 16725162
[TBL] [Abstract][Full Text] [Related]
12. Semantic memory in Alzheimer's disease: an analysis of category fluency.
Binetti G; Magni E; Cappa SF; Padovani A; Bianchetti A; Trabucchi M
J Clin Exp Neuropsychol; 1995 Feb; 17(1):82-9. PubMed ID: 7608305
[TBL] [Abstract][Full Text] [Related]
13. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
14. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
15. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
[TBL] [Abstract][Full Text] [Related]
16. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
17. Performance of everyday actions in mild Alzheimer's disease.
Ramsden CM; Kinsella GJ; Ong B; Storey E
Neuropsychology; 2008 Jan; 22(1):17-26. PubMed ID: 18211152
[TBL] [Abstract][Full Text] [Related]
18. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
Sager MA; Hermann B; La Rue A
J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
[TBL] [Abstract][Full Text] [Related]
19. The Semantic Object Retrieval Test (SORT) in normal aging and Alzheimer disease.
Kraut MA; Cherry B; Pitcock JA; Vestal L; Henderson VW; Hart J
Cogn Behav Neurol; 2006 Dec; 19(4):177-84. PubMed ID: 17159612
[TBL] [Abstract][Full Text] [Related]
20. Altered deactivation in individuals with genetic risk for Alzheimer's disease.
Persson J; Lind J; Larsson A; Ingvar M; Sleegers K; Van Broeckhoven C; Adolfsson R; Nilsson LG; Nyberg L
Neuropsychologia; 2008; 46(6):1679-87. PubMed ID: 18346764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
